Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders

Abstract

Study ObjectivesTo investigate the efficacy of melatonin compared to placebo in improving sleep parameters in patients with primary sleep disorders.DesignPubMed was searched for randomized, placebo-controlled trials examining the effects of melatonin for the treatment of primary sleep disorders. Primary outcomes examined were improvement in sleep latency, sleep quality and total sleep time. Meta-regression was performed to examine the influence of dose and duration of melatonin on reported efficacy.ParticipantsAdults and children diagnosed with primary sleep disorders.InterventionsMelatonin compared to placebo.ResultsNineteen studies involving 1683 subjects were included in this meta-analysis. Melatonin demonstrated significant efficacy in reducing sleep latency (weighted mean difference (WMD) = 7.06 minutes [95% CI 4.37 to 9.75], Z = 5.15, p<0.001) and increasing total sleep time (WMD = 8.25 minutes [95% CI 1.74 to 14.75], Z = 2.48, p = 0.013). Trials with longer duration and using higher doses of melatonin demonstrated greater effects on decreasing sleep latency and increasing total sleep time. Overall sleep quality was significantly improved in subjects taking melatonin (standardized mean difference = 0.22 [95% CI: 0.12 to 0.32], Z = 4.52, p<0.001) compared to placebo. No significant effects of trial duration and melatonin dose were observed on sleep quality.ConclusionThis meta-analysis demonstrates that melatonin decreases sleep onset latency, increases total sleep time and improves overall sleep quality. The effects of melatonin on sleep are modest but do not appear to dissipate with continued melatonin use. Although the absolute benefit of melatonin compared to placebo is smaller than other pharmacological treatments for insomnia, melatonin may have a role in the treatment of insomnia given its relatively benign side-effect profile compared to these agents.

Association of Urinary 6-Sulfatoxymelatonin (aMT6s) Levels and Objective and Subjective Sleep Measures in Older Men: The MrOS Sleep Study

“…Hence, both sleep and melatonin have been associated with various indicators of healthy aging. Moreover, randomized control trials confirm that administration of melatonin supplements improves sleep, compared to placebo among children and adults (15) as well as older adults (16) with sleep disorders.…”

Neuroendocrine-Metabolic Dysfunction and Sleep Disturbances in Neurodegenerative Disorders: Focus on Alzheimer’s Disease and Melatonin

“…Many published studies support a significant chronobiologic regulatory effect of melatonin on sleep. In a meta-analysis including 19 studies involving 1683 subjects, melatonin showed significant efficacy in reducing sleep latency and also increased total sleep time [97]. Trials of longer duration and the use of higher doses of melatonin demonstrated greater effects.…”

New Developments in Insomnia Medications of Relevance to Mental Health Disorders

“…Both agents have been found to have therapeutic effects only on sleep onset difficulties. 2,46,47 Adverse effects have been relatively limited and both are without abuse potential. Studies of melatonin are somewhat difficult to interpret because they have involved a variety of dosages, preparations, and timing of dosing.…”